Etripamil (MSP-2017) is under development for the treatment of transient cardiovascular conditions such as paroxysmal supraventricular tachycardia (PSVT), and atrial fibrillation. The drug candidate ...

1 Department of Cardiology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China 2 Department of Emergency, Shenzhen Second People's Hospital, The ...

rivoceranib in combination with camrelizumab for hepatocellular carcinoma and etripamil nasal spray (Cardamyst) for paroxysmal supraventricular tachycardia (PSVT).

Supraventricular arrhythmias are the most widespread group of arrhythmias and affect all age groups. Atrial fibrillation is the most common arrhythmic disorder and is even more prevalent among the ...

Introduction Supraventricular tachycardias (SVTs ... Of the 37 patients in the PARA group given adenosine, the tachycardia was successfully terminated in 81%. There was a 98% correlation between the ...

Furthermore, eight hours post-surgery, the patient developed paroxysmal supraventricular tachycardia (PSVT) with a peak heart rate of 225 beats per minute. An ice pack vagal maneuver was attempted ...

Future Cardiol. 2013;9(2):273-288.

Department of Paediatric Cardiology, Freeman Hospital, Newcastle upon Tyne, UK Correspondence to: Dr C Wren Department of Paediatric Cardiology, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK; ...

BPPV is a medical abbreviation for Benign Paroxysmal Positional Vertigo. It is a form of vertigo that is thought to be caused by calcium deposits within the inner ear. The medical term for these ...

MONTREAL and CHARLOTTE, N.C., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, and Chief Commercial Officer ...

After hours: 7:57:01 p.m. EST ...